Home > News > Latest > Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson

LAS VEGAS--(BUSINESS WIRE)--Oct. 26, 2016-- IBM (NYSE:IBM) and Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announce a significant expansion of their existing global e-Health alliance with a focus on two key healthcare challenges: the discovery of new treatment options and improving chronic disease management.